CS
TPTX
Candriam SCA’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-490,585
| Closed | -$36.9M | – | 902 |
|
|
2022
Q2 | $36.9M | Sell |
490,585
-12,703
| -3% | -$956K | 0.3% | 83 |
|
|
2022
Q1 | $13.5M | Sell |
503,288
-72,200
| -13% | -$1.94M | 0.09% | 210 |
|
|
2021
Q4 | $27.5M | Buy |
575,488
+54,863
| +11% | +$2.62M | 0.18% | 138 |
|
|
2021
Q3 | $34.6M | Hold |
520,625
| – | – | 0.24% | 101 |
|
|
2021
Q2 | $40.6M | Buy |
520,625
+63,684
| +14% | +$4.97M | 0.28% | 82 |
|
|
2021
Q1 | $53.5M | Sell |
456,941
-5
| -0% | -$585 | 0.45% | 50 |
|
|
2020
Q4 | $55.7M | Buy |
456,946
+221,783
| +94% | +$27M | 0.44% | 50 |
|
|
2020
Q3 | $20.5M | Sell |
235,163
-2,918
| -1% | -$255K | 0.19% | 131 |
|
|
2020
Q2 | $15.4M | Buy |
238,081
+85,441
| +56% | +$5.52M | 0.16% | 155 |
|
|
2020
Q1 | $9.3M | Buy |
152,640
+12
| +0% | +$731 | 0.1% | 225 |
|
|
2019
Q4 | $9.51M | Buy |
152,628
+119,628
| +363% | +$7.45M | 0.1% | 227 |
|
|
2019
Q3 | $1.24M | Buy |
+33,000
| New | +$1.24M | 0.02% | 570 |
|